Αποτελέσματα Αναζήτησης
REM Sleep Behavior Disorder (RBD) is a chronic sleep condition characterized by dream enactment and loss of REM atonia. Individuals often present to clinic with complaints of injury to themselves or their bed-partner due to violent movements during sleep.
1 Απρ 2023 · This systematic review is intended to provide supporting evidence for the accompanying clinical practice guideline 1 on the management of rapid eye movement (REM) sleep behavior disorder and update the evidence review conducted for the previously published American Academy of Sleep Medicine (AASM) Best Practice Guide. 2. BACKGROUND.
Best practice guide for the treatment of REM sleep behavior disorder (RBD). J Clin Sleep Med 2010;6(1):85-95. review and develop best practice principles. Work began in December 2007 to review and grade evidence in the peer-re-viewed scientific literature regarding the treatment of RBD in adults.
22 Μαρ 2024 · REM sleep is characterized by relaxed muscles, quick eye movement, irregular breathing, elevated heart rate, and increased brain activity. Most adults need about two hours of REM sleep each night. REM sleep plays a role in memory consolidation, emotional processing, brain development, and dreaming.
Rapid eye movement sleep behavior disorder (RBD) is diagnosed when dream enactment and complex motor behaviors occur during rapid eye movement (REM) sleep, accompanied by supportive evidence from loss of normal REM sleep muscle atonia known as REM sleep without atonia (RSWA) during polysomnography. 1 The prevalence of RBD has been estimated to b...
8 Φεβ 2023 · The guideline provides recommendations for specific medications, such as clonazepam and immediate-release melatonin, that clinicians should consider when treating REM sleep behavior disorder in adults.
15 Φεβ 2010 · Summary of Recommendations: Modifying the sleep environment is recommended for the treatment of patients with RBD who have sleep-related injury. Level A. Clonazepam is suggested for the treatment of RBD but should be used with caution in patients with dementia, gait disorders, or concomitant OSA.
